×
Psychemedics SG&A Expenses 2010-2024 | PMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Psychemedics sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
View More
Psychemedics SG&A Expenses 2010-2024 | PMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Psychemedics sg&a expenses from 2010 to 2024. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Related Stocks
Company Name
Market
Cap
Quest Diagnostics (DGX)
$18.6B
Encompass Health (EHC)
$11.1B
DaVita (DVA)
$10.5B
Elanco Animal Health (ELAN)
$7.3B
Chemed (CHE)
$6.6B
Option Care Health (OPCH)
$4.8B
RadNet (RDNT)
$4.3B
Amedisys (AMED)
$3.2B
Addus HomeCare (ADUS)
$2B
LifeStance Health (LFST)
$1.6B
Astrana Health (ASTH)
$1.3B
U.S Physical Therapy (USPH)
$1.1B
Pennant (PNTG)
$801M
Aveanna Healthcare Holdings (AVAH)
$786M
Atai Life Sciences (ATAI)
$707M
Daxor (DXR)
$44M
MEDIROM Healthcare Technologies (MRM)
$39M
Ontrak (OTRK)
$3M